[ad_1]
NEW YORK (Reuters Health) – In a new report, experimental contact lenses designed not only to improve vision, but also to prevent itching caused by allergies, may soon be used twice recently.
Lenses containing antihistamines, developed and tested by Johnson & Johnson, have significantly alleviated the symptoms of eye allergies, wrote researchers at the American magazine Corinthia.
"These are very encouraging results," said Brian Pal, director of clinical sciences at Vision Care Center of Johnson & Johnson, co-author of the study. "More than 20% of people with eye allergies … Big on their lives".
Randomized trials of Johnson & Johnson tested the effectiveness and safety of lenses slowly releasing anti-allergic Ketotifen. The trials included 244 volunteers aged 12 to 16 years.
Some volunteers wearing antihistamine lenses did not feel itchy, while others reported itching, but this was possible, Pal said.
"We are very excited to have the opportunity to write about this technology."
Dr. Christopher Starr welcomed the new discoveries.
"These are new and interesting results on many levels … I treat a lot of patients with seasonal allergies in New York," said Starr, an ophthalmologist and professor.
"I also suffer from itchy eyes and from the first moment I will use this product … in light of these positive data."
Pal said that he did not know when the new goals would go on sale.
Other medical news on euronews:
Source link
